{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:09:44Z","timestamp":1793088584248,"version":"4.5.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/cc-by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Inflammatory bowel disease (IBD) is a chronic disease whose etiology is not yet fully understood, and their course is characterized by periods of exacerbation and remission. In quite a few cases, actual disease remission may also accompany with inflammatory bowel disease (IBS)-like symptoms such as abdominal pain, bloating, flatulence, and diarrhea, may greatly impact quality of life. An army of strong evidence to support the FODMAPs diet (LFD) compounds as an effective dietary approach to IBS treatment. However, there is no significant evidence showing the effectiveness of LFD in treating quiescent IBD and its side effects; this lack of evidence is also an important factor hindering its promotion in the treatment of IBD and its complications. Therefore, this systematic review and meta-analysis will evaluate the efficacy and safety of LFD in the treatment of quiescent IBD patients with IBS-like symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>We searched the following databases from their establishment until December 2021: PubMed, Web of Science, Embase, Cochrane Library, CNKI, VIP, and Wanfang databases. No restrictions regarding publication date or language were applied. Keywords such as \u201cCrohn\u2019s disease,\u201d \u201culcerative colitis,\u201d \u201cinflammatory bowel disease,\u201d and \u201cFODMAPs\u201d have been combined for search. Ongoing and unpublished research in the Clinical Trials Registry Research will also be included. At the same time, we will manually search all reference lists from relevant systematic reviews for other eligible studies. The selected studies were randomized controlled clinical trials. We will meta-analyze the selected literature by Review Manager software (REVMAN v5.4 Cochrane Collaboration). Two researchers will independently review the research selection, data extraction, and research quality assessments. Finally, we will observe the outcome measures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study will provide evidence-based data for TFD treatment of IBD and provide new treatment options for future clinical applications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>The protocol of the systematic review does not require ethical approval because it does not involve humans. This article will be published in peer-reviewed journals and presented at relevant conferences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration Number:<\/jats:title>\n            <jats:p>INPLASY202220060<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029088","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:04:50Z","timestamp":1648731890000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Effects of low-FODMAP diet on irritable bowel symptoms in patients with quiescent inflammatory bowel disease"],"prefix":"10.1097","volume":"101","author":[{"given":"Baijian","family":"Gu","sequence":"first","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun City, Jilin Province, China,Proctology, First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun City, Jilin Province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Yu","sequence":"additional","affiliation":[{"name":"Urology, First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun City, Jilin Province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Shi","sequence":"additional","affiliation":[{"name":"Proctology, First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun City, Jilin Province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqiu","family":"Yan","sequence":"additional","affiliation":[{"name":"Proctology, First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun City, Jilin Province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixin","family":"Chen","sequence":"additional","affiliation":[{"name":"Electronic data processing management science, Health Information Center of Jilin Province, Changchun City, Jilin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-1050","authenticated-orcid":false,"given":"Jianhua","family":"Zhou","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun City, Jilin Province, China,Proctology, First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun City, Jilin Province, China,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"R1-49-20250504","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.suc.2019.08.001","article-title":"Inflammatory bowel disease presentation and diagnosis.","volume":"99","author":"Flynn","year":"2019","journal-title":"Surg Clin North Am"},{"key":"R2-49-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: inflammatory bowel diseases.","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R3-49-20250504","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13073-018-0558-x","article-title":"Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease.","volume":"10","author":"Mo","year":"2018","journal-title":"Genome Med"},{"key":"R4-49-20250504","first-page":"117","article-title":"A potential \u2018curative\u2019 modality for Crohn\u2019s disease\u2014modeled after prophylaxis of bovine Johne\u2019s disease.","volume":"2","author":"Click","year":"2012","journal-title":"Mycobact Dis"},{"key":"R5-49-20250504","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1365-2036.2005.02506.x","article-title":"Personal view: food for thought\u2014western lifestyle and susceptibility to Crohn\u2019s disease. The FODMAP hypothesis.","volume":"21","author":"Gibson","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R6-49-20250504","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cgh.2016.05.012","article-title":"Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease.","volume":"15","author":"Gracie","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-49-20250504","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1053\/j.gastro.2017.06.010","article-title":"A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: a randomized controlled trial.","volume":"153","author":"Staudacher","year":"2017","journal-title":"Gastroenterology"},{"key":"R8-49-20250504","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.3390\/nu11122856","article-title":"Effect of structural individual low-FODMAP dietary advice vs. brief advice on a commonly recommended diet on IBS symptoms and intestinal gas production.","volume":"11","author":"Patcharatrakul","year":"2019","journal-title":"Nutrients"},{"key":"R9-49-20250504","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/j.gastro.2015.07.054","article-title":"Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.","volume":"149","author":"B\u00f6hn","year":"2015","journal-title":"Gastroenterology"},{"key":"R10-49-20250504","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"R11-49-20250504","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R12-49-20250504","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-49-20250504","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"R14-49-20250504","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R15-49-20250504","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/cells8070659","article-title":"Inflammatory bowel disease: a stressed \u201cgut\/feeling\u201d.","volume":"8","author":"Oligschlaeger","year":"2019","journal-title":"Cells"},{"key":"R16-49-20250504","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.3390\/nu12123751","article-title":"Diet advice for Crohn\u2019s disease: FODMAP and beyond.","volume":"12","author":"Popa","year":"2020","journal-title":"Nutrients"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:23:22Z","timestamp":1746332602000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029088"}},"subtitle":["A protocol for a systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029088","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"2022-02-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}